AUTHOR=Yuan Min , Zhu Zhongzheng , Mao Wei , Wang Hui , Qian Hong , Wu Jianguo , Guo Xianling , Xu Qing 

TITLE=Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

JOURNAL=Frontiers in Oncology

VOLUME=11

YEAR=2022

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.796625

DOI=10.3389/fonc.2021.796625

ISSN=2234-943X